다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Keros Therapeutics Inc (KROS)
Keros Therapeutics Inc (KROS) 뉴스

KROS

Keros Therapeutics (KROS)

Keros Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KROS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	23:00	GlobeNewswire Inc.	Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association	NASDAQ:KROS	Keros Therapeutics Inc
2024/05/08	21:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KROS	Keros Therapeutics Inc
2024/05/08	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2024/05/08	21:00	GlobeNewswire Inc.	Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results	NASDAQ:KROS	Keros Therapeutics Inc
2024/03/14	21:00	GlobeNewswire Inc.	Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes	NASDAQ:KROS	Keros Therapeutics Inc
2024/03/06	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2024/03/05	22:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2024/03/05	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2024/03/05	22:00	GlobeNewswire Inc.	Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference	NASDAQ:KROS	Keros Therapeutics Inc
2024/02/29	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2024/02/29	06:01	GlobeNewswire Inc.	Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:KROS	Keros Therapeutics Inc
2024/02/24	07:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KROS	Keros Therapeutics Inc
2024/02/16	10:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KROS	Keros Therapeutics Inc
2024/02/16	10:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KROS	Keros Therapeutics Inc
2024/02/16	10:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KROS	Keros Therapeutics Inc
2024/02/16	10:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/29	22:00	GlobeNewswire Inc.	Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/09	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/09	22:00	GlobeNewswire Inc.	Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/09	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/05	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/05	06:04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/05	06:02	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/04	11:29	GlobeNewswire Inc.	Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/04	06:05	GlobeNewswire Inc.	Keros Therapeutics Announces Proposed Public Offering of Common Stock	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/04	06:04	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:KROS	Keros Therapeutics Inc
2024/01/03	22:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2023/12/11	20:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc
2023/12/11	20:00	GlobeNewswire Inc.	Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition	NASDAQ:KROS	Keros Therapeutics Inc
2023/11/07	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KROS	Keros Therapeutics Inc

검색 관련기사 보기:NASDAQ:KROS

1 2 3 4 5 6 7 8 9 10 다음 >>

Alliance Entertainment (PK)

Ottawa Savings Bancorp

Xtrackers MSCI China A E...

Cr Bolzano Tf 0,5% Gn28 ...

CAC 40 Equal Weight Gros...

Kb Leverage Gold Futures...

Intellabridge Technology (QB)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관